WAM
TVGN icon

Wolverine Asset Management’s Tevogen Inc. Common Stock TVGN Stock Holding History

Wolverine Asset Management’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,497
Closed -$2.44M – 2021
2023
Q3 		$2.44M Buy
+4,497
New +$2.43M 0.03% 497
2023
Q1 		– Sell
-7,676
Closed -$3.96M – 2121
2022
Q4 		$3.96M Buy
7,676
+7,633
+17,751% +$3.91M 0.04% 393
2022
Q3 		$21K Sell
43
-5,026
-99% -$2.53M ﹤0.01% 1822
2022
Q2 		$2.54M Sell
5,069
-5,725
-53% -$2.87M 0.03% 488
2022
Q1 		$5.39M Buy
+10,794
New +$5.37M 0.05% 281

Other funds holding TVGN

MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Wolverine Asset Management's TVGN Position: Q4 2023 in Review

Wolverine Asset Management sold out of Tevogen Inc. Common Stock (TVGN) in Q4 2023, closing a stake of 4,497 shares — an estimated $2.44M sold.

Wolverine Asset Management first reported a position in TVGN in Q1 2022 and held it in 5 quarters. The position peaked at $5.39M in Q1 2022. 6 funds tracked by Wall St. Rank hold TVGN as of Q4 2023.

  • Wolverine Asset Management reported no remaining Tevogen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Wolverine Asset Management sold 4,497 Tevogen Inc. Common Stock shares in Q4 2023, an estimated $2.44M.
  • Wolverine Asset Management first reported a position in Tevogen Inc. Common Stock in Q1 2022 and held it in 5 quarters.
  • Wolverine Asset Management's Tevogen Inc. Common Stock position peaked at $5.39M in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q4 2023.

Based on Wolverine Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.